Clinical trials recruiting in Argenteuil, France
8
Recruiting trials
9
Conditions
Phase breakdown
Phase 3 4Not applicable 4
Conditions recruiting in Argenteuil, France
Recruiting trials in Argenteuil, France
- A Real-world Study to Evaluate the Effectiveness of Deucravacitinib in Adults With Plaque Psoriasis in France (RePhlect)
- A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy
- A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis
- Assessment of the Effect of a Dermatology-Oriented Spa Therapy on the Quality of Life of Patients With Psoriasis
- Chemotherapy De-escalation in HR +, HER2-, Intermediate-risk Early Breast Cancer Treated With Adjuvant Ribociclib
- PRostate Olaparib Real World Evidence Study
- Phase III Study Evaluating Induction Chemotherapy Followed by Chemoradiotherapy Compared to Standard Chemoradiotherapy for Locally Advanced SCCA
- REBECCA Real-world Early BrEast CanCer mAnagement
Common questions
How many clinical trials are recruiting in Argenteuil, France?
8 recruiting trials have at least one study site in Argenteuil, France.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.